Tolcapone Patent Expiration
Tolcapone is Used for managing symptoms of Parkinson's disease. It was first introduced by Bausch Health Us Llc
Tolcapone Patents
Given below is the list of patents protecting Tolcapone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tasmar | US5476875 | Catechol derivatives |
Dec 19, 2012
(Expired) | Bausch |
Tolcapone's Family Patents
Explore Our Curated Drug Screens
Tolcapone Generic API Manufacturers
Several generic applications have been filed for Tolcapone. The first generic version for Tolcapone was by Endo Operations Ltd and was approved on Mar 26, 2015. And the latest generic version is by Alvogen Inc and was approved on Jul 29, 2020.
Given below is the list of companies who have filed for Tolcapone generic, along with the locations of their manufacturing plants worldwide.
1. ALVOGEN
Alvogen Inc has filed for 1 generic for Tolcapone. Given below are the details of the strengths of this generic introduced by Alvogen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Discontinued | ORAL | N/A | Jul 29, 2020 |
Manufacturing Plant Locations New
Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
2. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 1 generic for Tolcapone. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Sa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Discontinued | ORAL | N/A | Aug 1, 2019 |
3. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Tolcapone. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Discontinued | ORAL | N/A | Mar 26, 2015 |
4. NOVAST LABS
Novast Laboratories Ltd has filed for 1 generic for Tolcapone. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Prescription | ORAL | AB | Aug 7, 2018 |